0001127602-23-010853.txt : 20230320
0001127602-23-010853.hdr.sgml : 20230320
20230320162736
ACCESSION NUMBER: 0001127602-23-010853
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230316
FILED AS OF DATE: 20230320
DATE AS OF CHANGE: 20230320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guerrero Ramiro
CENTRAL INDEX KEY: 0001913253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 23746660
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-03-16
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913253
Guerrero Ramiro
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
0
Common Stock
2023-03-16
4
P
0
1333
3.64
A
301709.04
D
The purchases in this Form 4 were automatically effected pursuant to a previously executed purchasing plan for Mr. Guerrrero that is intended to comply with the Rule 10b5-1(c) promulgated under the Securites Exchange Act of 1934, as amended.
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.55 to $3.70, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
/s/ Ramiro Guerrero
2023-03-20